Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database

被引：0

作者：

Mullerova, Hana ^{[1
]}

Gelhorn, Heather ^{[2
]}

Wilson, Hilary ^{[2
]}

Benson, Victoria ^{[1
]}

Karlsson, Niklas ^{[3
]}

Menjoge, Shailendra ^{[4
]}

Merrill, Debora ^{[5
]}

Rennard, Stephen ^{[6
]}

Tal-Singer, Ruth ^{[7
]}

Tabberer, Margaret ^{[8
]}

Jones, Paul ^{[9
]}

机构：

[1] GSK, Resp Epidemiol, Uxbridge, Middx, England

[2] Evidera, Stat, Bethesda, MD USA

[3] AstraZeneca R&D, Dept, Molndal, Sweden

[4] Boehringer Ingelheim Pharmaceut Inc, Biometr & Data Management, Ridgefield, CT 06877 USA

[5] COPD Fdn, COPD Biomarkers Qualificat Consortium, Washington, DC USA

[6] Nebrasca Med Ctr, Div Pulm Crit Care Sleep & Allergy, Omaha, NE USA

[7] GSK, COPD Clin Discovery, King Of Prussia, PA USA

[8] GSK, Value Evidence&Outcomes, Uxbridge, Middx, England

[9] St Georges Univ London, Inst Infect & Immun, London, England

来源：

关键词：

COPD; -; management; Longitudinal study; Quality of life;

D O I：

10.1183/13993003.congress-2015.PA3017

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

PA3017

引用

页数：2